Study of Glow800 device during brain or reconstructive surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests the GLOW800 device which uses a special dye (ICG) to help surgeons see blood flow during brain or reconstructive surgery. It aims to confirm the device works as intended.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for brain surgery on blood vessels or for plastic/reconstructive surgery.
- You will receive the dye ICG (Indocyanine Green) during surgery.
- You or your legal representative agree to sign a consent form.
- You are not allergic to ICG or have had severe reactions to iodine-based substances.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
This trial tests a special headset that helps surgeons see better during operations using fluorescent dyes. It may improve surgical accuracy and safety for people undergoing brain, vascular, or reconstructive surgery.
This trial compares two dyes used during stomach or intestine surgery to see which helps surgeons see the blood flow better. It may help decide which dye works best for safe reconnections.
This study tests a tiny amount of a dye called Indocyanine Green (ICG) during surgery to see if it safely shows blood flow to the gut and urinary organs. It may help doctors check that these organs are getting enough blood during the operation.
This trial tests a dye (SBK2-ICG) that makes brain tumors glow during surgery. It's a safety study to see if the dye is safe and works well, which might help surgeons remove brain tumors more completely.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
Hear when a new Reconstructive Surgical Procedures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.